Outcomes by Design

Onsera Health

Outcomes by Design is Onsera Health’s flagship webinar and podcast series exploring one of healthcare’s most urgent questions: Why are we spending more — but achieving less? Each episode brings together clinical leaders, behavioral scientists, employers, and health system strategists to unpack the structural drivers behind rising cardiometabolic disease, obesity, and employer healthcare costs. Rather than focusing on symptoms or short-term savings, the series reframes health through a systems lens — examining prevention, predictive care, behavior change, and value-based design.

Episodes

  1. Jul 9

    What Happens After the Weight Comes Off?

    Weight loss is only the beginning. The real question is: **what happens after the weight comes off?** In this episode of *Outcomes by Design*, Dr. Kristin Baier, Chief Medical Officer at Onsera Health, sits down with obesity medicine expert Dr. Melanie Jay to explore the latest evidence on long-term obesity treatment, weight maintenance, and why obesity should be treated as the chronic disease it is. Together, they discuss: * What the latest BMJ meta-analysis reveals about weight regain after stopping GLP-1 medications * Why obesity requires long-term treatment—not short-term solutions * The biology behind weight maintenance and metabolic adaptation * What employers and benefit leaders should know when evaluating obesity care programs * Why lasting outcomes depend on more than medication alone * The critical role of physicians, registered dietitians, health coaches, and ongoing clinical support Whether you're a healthcare leader, employer, clinician, or simply interested in the future of obesity care, this conversation offers an evidence-based perspective on what it truly takes to improve long-term health outcomes. Subscribe for more conversations on the evidence, innovations, and strategies shaping the future of healthcare outcomes. #ObesityCare #GLP1 #WeightManagement #EmployerHealth #HealthcareInnovation #PopulationHealth #BenefitsLeadership #ChronicDisease #HealthOutcomes #Healthcare

    What Happens After the Weight Comes Off?

  2. Jul 1

    Episode 6: Beyond Longevity: The Future of Healthspan, Prevention, and Healthcare

    What if the future of healthcare isn't about helping people live longer—but helping them live healthier for longer? In this episode of **Outcomes by Design**, Dr. Kristin Baier sits down with **Dr. Clive Meanwell**, physician, entrepreneur, and Chairman & Partner at Population Health Partners, for a conversation on one of healthcare's biggest opportunities: closing the gap between **lifespan and healthspan**. Together, they explore why today's healthcare system is still largely built around treating disease instead of preventing it—and what it will take to fundamentally change that. In this episode, you'll learn: • What "healthspan" really means—and why it matters more than longevity alone • The staggering economic and societal cost of preventable chronic disease • Why prevention remains underfunded despite overwhelming evidence • How AI is transforming healthcare, clinical decision-making, and patient engagement • The future of GLP-1 therapies beyond weight loss • Why empathy, coaching, and human connection remain essential in an AI-powered healthcare system • How Population Health Partners is investing in the next generation of healthcare innovation Whether you're an employer, healthcare leader, clinician, benefits professional, or simply interested in the future of medicine, this conversation offers a compelling look at where healthcare is headed—and why now is the time to rethink how we define success. 🎙️ Subscribe for more conversations with the leaders shaping the future of obesity care, metabolic health, AI, and healthcare innovation. Learn more about Onsera Health: https://onserahealth.com

    Episode 6: Beyond Longevity: The Future of Healthspan, Prevention, and Healthcare

  3. Jun 3

    Episode 5: From Injection to Intention: Nutrition in the Age of GLP-1s

    In Episode 5 of Outcomes by Design, Dr. Kristin Baier (Chief Medical Officer at OnSERA) sits down with Sheena Batura, Head of Nutrition, to explore a critical shift in healthcare: what nutrition looks like in the age of GLP-1 medications. As GLP-1s transform weight management, the role of nutrition is evolving—from restriction to optimization. This conversation dives into how patients can achieve better outcomes by combining medication with intentional nutrition, behavioral support, and personalized care. Topics covered include: The shift from dieting to nutrition optimization Protein, fiber, and what really matters for sustainable health Managing side effects through diet The impact of GLP-1s on “food noise” and emotional eating Why multidisciplinary support is essential for long-term success Nutrition strategies for active individuals and athletes Bottom line: GLP-1s don’t replace nutrition—they raise the standard for how we approach it. Subscribe for more conversations on designing better health outcomes.

    Episode 5: From Injection to Intention: Nutrition in the Age of GLP-1s

  4. May 14

    Episode 4: GLP-1s, Cost Pressure, and the Future of Drug Access

    Healthcare is hitting a breaking point—and it’s not where most people think. We’re seeing unprecedented demand for high-impact medications like GLP-1s 💉 At the same time, coverage is tightening, prior authorization is expanding, and access is becoming harder—not easier. So what’s really going on?! In this episode of Outcomes by Design, Kristin Baier MD sat down with Chronis Manolis, former Chief Pharmacy Officer at UPMC, to unpack the growing tension between access and affordability. A few takeaways: → Coverage isn’t just about price—it’s a response to system-wide cost pressure → Prior authorization is becoming a defining barrier to care → We’re restricting access to treatments that could reduce long-term costs → Medication alone isn’t the solution—support systems matter just as much And maybe... most importantly... we’ve been here before 📢 From statins to SSRIs, history shows us that high-demand therapies often start with resistance—and end as standard of care. The question is: how long will it take us to get there this time? If we want better outcomes, we need better coordination across pharma, health plans, employers, and care delivery. This isn’t a single-player problem—and it won’t be solved that way. ▶️ YouTube: https://lnkd.in/euD_6_P3 🎧 Apple Podcasts: https://lnkd.in/e4QQQQGP 🎵 Spotify: https://lnkd.in/e5yhMx4a

    Episode 4: GLP-1s, Cost Pressure, and the Future of Drug Access

  5. Apr 15

    Episode 3: Building a Weight Loss Strategy That Actually Delivers ROI

    Episode 3: GLP-1s, Employee Wellbeing & the Future of Benefits | Featuring Samira Lowman (CHRO, Onsera) In this episode of Outcomes By Design, Kristin sits down with Samira Lowman, Chief Human Resources Officer at Onsera Health, to unpack one of the most important (and rapidly evolving) topics in employer healthcare: GLP-1 medications and weight loss benefits. As GLP-1s reshape the landscape of workforce health, HR leaders are being asked to make complex decisions—balancing cost, care, and long-term outcomes. Samira brings a unique perspective from the front lines, sharing how employers can think strategically about supporting employees while building sustainable, high-impact benefits programs. 🔑 What We Cover in This Episode - How to balance employee wellbeing investment vs. rising healthcare costs - The real ROI conversation behind GLP-1 coverage - Why focusing only on short-term costs can be a costly mistake - The biggest “watch outs” for CHROs evaluating weight loss solutions - What a best-in-class metabolic health benefit should look like in 2026 - Why support infrastructure (coaching, nutrition, care coordination) is critical beyond the medication itself - How employers can drive long-term behavior change and better outcomes - Why weight loss solutions still matter—even as GLP-1 drug prices evolve 💡 Key Takeaway Access to medication alone isn’t enough. Sustainable results—and real cost savings—come from comprehensive, coordinated support systems that drive adherence, behavior change, and long-term health outcomes. 👥 Who This Is For - HR Leaders & CHROs - Benefits Managers & Consultants - Employers navigating GLP-1 coverage decisions - Anyone interested in the future of population health and workplace wellbeing 📌 Final Thought from Samira “Long-term value creation means investing in employee wellbeing with sustainability in mind—not just quick wins. The right investment today drives meaningful cost savings tomorrow.” 👉 Don’t forget to like, subscribe, and follow Outcomes By Design for more conversations at the intersection of healthcare, benefits, and innovation.

    Episode 3: Building a Weight Loss Strategy That Actually Delivers ROI

  6. Mar 5

    Episode 2: Advocacy & The Future of Obesity Care

    Outcomes By Design: Advocacy and the Future of Obesity Care In this episode, Kristin Baier MD Baier is joined by Joe Nadglowski, President & CEO of the Obesity Action Coalition, for a powerful conversation about the state of obesity care. Together, they discuss: 🔹 Why obesity must be treated as a chronic disease — not a choice 🔹 The impact of weight bias in healthcare 🔹 Systemic barriers to accessing evidence-based treatment 🔹 What meaningful policy change could look like 🔹 And how advocacy is shaping the future of care This episode centers the patient voice and challenges us to rethink how systems, language, and coverage design influence outcomes. + follow us and turn episode reminders:

    Episode 2: Advocacy & The Future of Obesity Care

  7. Feb 16

    Episode 1: Why Metabolic Health Fails Without Systems

    Reframing Obesity: From Willpower to Chronic Disease Care Obesity isn’t a motivation problem. It’s a chronic, biologically driven disease — and treating it any other way is costing employers, health plans, and patients billions in realized spend without realized outcomes. Join Dr. Kristin Baier, Jeff Bernhard, and Lisa Schaffner, PhD as they break down: • Why traditional cost-containment strategies keep failing • The systems problem behind rising cardiometabolic risk • How employers can shift from reactive claims management to proactive risk design • What evidence-based obesity care should actually look like This is the conversation healthcare leaders need to be having.

    Episode 1: Why Metabolic Health Fails Without Systems
  • 7 Episodes

About

Outcomes by Design is Onsera Health’s flagship webinar and podcast series exploring one of healthcare’s most urgent questions: Why are we spending more — but achieving less? Each episode brings together clinical leaders, behavioral scientists, employers, and health system strategists to unpack the structural drivers behind rising cardiometabolic disease, obesity, and employer healthcare costs. Rather than focusing on symptoms or short-term savings, the series reframes health through a systems lens — examining prevention, predictive care, behavior change, and value-based design.

Information